Synergy CHC Corp.

SNYR Nasdaq CIK: 0001562733

Company Information

Industry Medicinal Chemicals & Botanical Products
SIC Code 2833
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation NV
Business Address 865 SPRING STREET, WESTBROOK, ME, 04092
Mailing Address 865 SPRING STREET, WESTBROOK, ME, 04092
Phone 615-939-9004
Fiscal Year End 1231
EIN 990379440

Financial Overview

FY2024

$16.34M
Total Assets
$39.55M
Total Liabilities
-$33.52M
Stockholders' Equity
$0.86
EPS

Recent SEC Filings

Form Type Date Filed Document
8-K Current report of material events March 25, 2026 View on SEC
8-K Current report of material events March 3, 2026 View on SEC
424B5 Prospectus supplement December 9, 2025 View on SEC
S-3 Shelf registration for future offerings November 26, 2025 View on SEC
8-K Current report of material events November 13, 2025 View on SEC
10-Q Quarterly financial report November 13, 2025 View on SEC
3 Initial insider ownership report October 2, 2025 View on SEC
4 Insider stock transaction report September 22, 2025 View on SEC
8-K Current report of material events September 22, 2025 View on SEC
4 Insider stock transaction report September 22, 2025 View on SEC

Material Events

8-K Financial Distress March 25, 2026
High Impact
  • Renegotiated $22.5 million debt to improve immediate cash flow
  • Secured operational breathing room for marketing and inventory
View Analysis
8-K Legal Issue March 3, 2026
High Impact
  • Synergy CHC Corp. (SNYR) faces a significant setback with the termination of a key international licensing agreement.
  • The agreement, covering FOCUSfactor and Flat Tummy Co. products in UAE and Turkey, was terminated 'ab initio'.
View Analysis

Related Companies

Companies in the same industry (SIC: 2833)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.